Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$22.62 - $39.32 $316 - $550
14 New
14 $0
Q3 2022

Nov 09, 2022

SELL
$40.66 - $53.03 $1,097 - $1,431
-27 Reduced 41.54%
38 $2,000
Q2 2022

Aug 12, 2022

BUY
$40.85 - $77.67 $817 - $1,553
20 Added 44.44%
65 $3,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $2,351 - $3,517
29 Added 181.25%
45 $4,000
Q3 2021

Nov 12, 2021

BUY
$101.99 - $166.36 $1,631 - $2,661
16 New
16 $2,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.